The risky business of dopamine agonists in Parkinson disease and impulse control disorders.

Title
The risky business of dopamine agonists in Parkinson disease and impulse control disorders.
Authors
Keywords
-
Journal
BEHAVIORAL NEUROSCIENCE
Volume 125, Issue 4, Pages 492-500
Publisher
American Psychological Association (APA)
Online
2011-05-24
DOI
10.1037/a0023795

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now